(NYSE: DHR) Danaher's forecast annual revenue growth rate of 0.36% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.65%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 71.53%.
Danaher's revenue in 2023 is $31,250,000,000.On average, 6 Wall Street analysts forecast DHR's revenue for 2023 to be $22,831,010,507,115, with the lowest DHR revenue forecast at $22,535,541,365,814, and the highest DHR revenue forecast at $23,142,378,353,828.
In 2024, DHR is forecast to generate $24,514,386,401,430 in revenue, with the lowest revenue forecast at $24,030,179,826,306 and the highest revenue forecast at $24,768,930,935,550.